Chronic Inflammatory Bowel Diseases (IBD) and School Absenteeism (MICI School)

March 8, 2019 updated by: Rennes University Hospital

Chronic Inflammatory Bowel Diseases and School Absenteeism

Study of the causes and rate of school absenteeism in children and adolescents with Inflammatory Bowel Disease.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

108

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Rennes, France, 35200
        • CHU de Rennes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with IBD

Description

Inclusion Criteria:

  • Child aged 6 to 18 years old
  • Child with definite diagnosis of IBD for at least 6 months
  • Follow-up by a gastroenterologist of Rennes University Hospital on a regular basis (at least 2 annual consultations)
  • Non-opposition of the child and the parents

Exclusion Criteria:

  • School leaving
  • Student at the University
  • Other serious disease outside IBD preventing normal schooling
  • Refusal of participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with IBD
Other: Questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of days of absence from school due to IBD
Time Frame: Month 10
Month 10

Secondary Outcome Measures

Outcome Measure
Time Frame
Comparison of the rate of school absenteeism of a child with IBD to the data of the school academy where she/he is enrolled
Time Frame: Month 10
Month 10
Study of repercussion of the number of days of absence due to IBD on school results
Time Frame: Month 10
Month 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rennes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Actual)

February 28, 2018

Study Completion (Actual)

February 28, 2018

Study Registration Dates

First Submitted

August 30, 2017

First Submitted That Met QC Criteria

August 31, 2017

First Posted (Actual)

September 1, 2017

Study Record Updates

Last Update Posted (Actual)

March 11, 2019

Last Update Submitted That Met QC Criteria

March 8, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 35RC16_3035_MICI School

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Bowel Diseases

Clinical Trials on Questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe